dbv-technologies.com (DBVT) - Volume dodolan perusahaan

DBV Technologies S.A. (DBVT) maintains a global raw material sourcing strategy that ensures production stability, as reflected in the company's consolidated sales trend. The value 0.00 serves as the current parameter value on the chart. Growth is driven by expectations for FDA approval of pediatric therapy and demand for Viaskin, while unique epidermal patents protect the product from pressure from oral medication manufacturers.

DBVT - Dodolan perusahaan DBV Technologies S.A. ing rentang 04.07.2022 - 13.11.2026

Rincian analitis perusahaan DBV Tech (DBVT)

- rega saiki lan proyeksi nilai saham:

Kurs saham DBV Technologies SA|DBVT - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Kapitalisasi pasar DBV Technologies S.A.|DBVT - Nilai Perusahaan

- statistik nilai buku emiten:

Aset Bersih saben Siji Saham DBV Technologies|DBVT - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku dbv-technologies.com|DBVT - Gunggung Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Rasio Kabeh Utang marang Dana Pribadi DBV Technologies S.A.|DBVT - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal DBV Technologies SA|DBVT - Gunggung utang perusahaan|Utang-utang marang nilai buku DBV Technologies S.A.|DBVT - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan DBV Technologies|Rasio jangkoan perantara dbv-technologies.com

- statistik bathi lan rasio pasar:

DBVT - Bathi resik perusahaan|Prakiraan bathi resik DBV Technologies S.A.|DBVT - Rasio rega marang bathi|Rasio prakiraan rega marang bathi DBV Technologies SA|DBVT - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan DBV Technologies S.A.|DBVT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan DBV Technologies|DBVT - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham sajroning taun lumaku dbv-technologies.com|DBVT - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep DBV Technologies S.A.

- rincian pendapatan lan dodolan emiten:

DBVT - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan DBV Technologies SA|DBVT - Rasio rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake DBV Technologies S.A.

Ringkesan analisis perusahaan:DBVT (dbv-technologies.com)

Portfolio managers assess the operational resilience of DBV Technologies S.A. (DBVT) through product sales revenue. This metric aggregates all cash inflows from shipments, reflecting real demand for innovative solutions. By analyzing the company's sales history, investors can track the dynamics of insurance reimbursements for the use of Viaskin patches. Growth in this indicator confirms expansion within the food allergy therapy market, while a stable trend underscores the strength of the issuer's market position.

Pesaing wigati

Volume dodolan perusahaan KRYS (Krystal Biotech Corp.)|Pendapatan lan volume dodolan APGE|arcutis.com - Volume dodolan perusahaan|Pendapatan lan volume dodolan VCEL (Vericel)|Oruka Therapeutics, Inc. - Pendapatan perusahaan|SMTI: Dodolan perusahaan|SLSN: Pendapatan perusahaan|DERM (journeymedicalcorp.com) - Dodolan perusahaan|fortebiorx.com - Pendapatan dodolan perusahaan|Dodolan perusahaan EMPG|SLGL (Sol-Gel Technologies Ltd) - Total dodolan perusahaan|Pendapatan lan volume dodolan AXIL|MDCX - Total pendapatan perusahaan|Pendapatan lan volume dodolan VRCA (Verrica Pharmaceuticals Inc.)|HOTH - Dodolan perusahaan|Biofrontera Inc - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan VYNE (VYNE Therapeutics)|sonomapharma.com (SNOA) - Pendapatan perusahaan|Volume dodolan perusahaan QNRX|Pendapatan perusahaan Azitra, Inc.|Total pendapatan perusahaan dermatarx.com DRMA|Pendapatan perusahaan Elevai Labs (ELAB)|Pendapatan perusahaan RVNC (Revance Therapeutics Inc.)